한글목차

세계 메테나민 시장은 2024년에는 50만 2,720톤에 달했고, 2035년에는 70면 940톤에 달할 것으로 예상되며, 예측 기간 동안 연평균 성장률(CAGR)은 3.59%를 나타낼 것으로 예상됩니다.

메테나민 세계 시장 역학은 역동적이며, 다양한 산업 분야의 광범위한 응용 분야가 시장을 주도하고 있습니다. 헥사메틸렌테트라민으로도 알려진 메테나민은 의약품, 플라스틱 및 소독제로 널리 사용되고 있습니다. 제약 부문에서는 요로감염증(UTI) 치료에 중요한 역할을 하며, 특정 박테리아 균주와 싸우는 항균성을 발휘합니다. 세계보건기구(WHO)의 보고서에 따르면, 세균 감염에서 일반적인 항생제에 대한 내성이 증가하고 있는 것이 수요 증가에 기여하고 있습니다. 성병의 주요 원인인 임균 분리균의 60% 이상이 널리 사용되는 항생제인 시프로플록사신에 내성을 보이고 있습니다. 또한 요로결석의 주요 원인인 대장균 균주의 20% 이상이 1차 치료제(암피실린, 코트리목사졸)와 2차 치료제(플루오로퀴놀론)에 모두 내성을 보이고 있습니다.

주요 시장 성장 촉진요인

메테나민에 대한 제약 분야에서 수요 증가

주요 시장 과제

규제 장벽과 컴플라이언스 문제

주요 시장 동향

메테나민 생산 기술 발전

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 메테나민 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율과 예측
  • 용도별(합성 수지, 고무 산업, 섬유 산업, 기타)
  • 판매채널별(직접 판매, 간접 판매)
  • 기업별(2024년)
  • 지역별
• 시장 맵

제6장 북미의 메테나민 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 멕시코
  • 캐나다

제7장 유럽의 메테나민 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 독일
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 메테나민 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 인도
  • 한국
  • 일본
  • 호주

제9장 남미의 메테나민 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 메테나민 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트(UAE)

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 인수합병(M&A)(해당하는 경우)
• 제품 발매(해당하는 경우)

제13장 Porter의 Five Forces 분석

• 산업내 경쟁
• 신규 참여 가능성
• 공급업체의 힘
• 고객의 힘
• 대체품의 위협

제14장 경쟁 구도

• Shandong Shengxuelong Chemical Co., Ltd.
• UCC Shchekinoazot
• Sina Chemical Industries Company
• Henan Runhua Chemicals Co.,Ltd
• Guangzhou Hanpu Pharmaceutical Co Ltd
• Zaozhuang xudong chemical technology co., ltd.
• Simalin Chemical Industries Private Limited

제15장 전략적 제안

제16장 리서치사에 대해 & 면책사항

영문목차

The global Methenamine market was valued at 502.72 thousand tonnes in 2024 and is projected to reach 740.94 thousand tonnes by 2035, registering a Compound Annual Growth Rate (CAGR) of 3.59% over the forecast period.

The global Methenamine market is dynamic and driven by its broad range of applications across various industries. Methenamine, also known as hexamethylenetetramine, is widely used in pharmaceuticals, plastics, and as a disinfectant. In the pharmaceutical sector, it plays a critical role in treating urinary tract infections (UTIs), offering antimicrobial properties that combat specific bacterial strains. According to a World Health Organization (WHO) report, the growing resistance to common antibiotics in bacterial infections is contributing to increased demand. Over 60% of Neisseria gonorrhoeae isolates, a major cause of sexually transmitted infections, have shown resistance to ciprofloxacin, a widely used antibiotic. Additionally, more than 20% of E. coli isolates, a leading cause of UTIs, demonstrate resistance to both first-line (ampicillin, co-trimoxazole) and second-line (fluoroquinolones) treatments.

Key Market Drivers

Growing Demand for Methenamine in Pharmaceutical Applications

One of the main drivers of the global Methenamine market is its increasing use in the pharmaceutical industry, especially for its antimicrobial properties in treating UTIs. As UTIs remain one of the most common bacterial infections worldwide, the rising prevalence of these infections, particularly among women and the elderly, is fueling demand for Methenamine-based treatments. Methenamine is highly effective at preventing bacterial growth in the urinary tract and is frequently prescribed in combination with other drugs to enhance its therapeutic effects. In September 2024, Mankind Pharma Ltd. introduced its RAPID NEWS self-test kits to address prevalent health concerns such as UTIs, dengue, and early menopause. This innovation aims to make healthcare more accessible by offering individuals across India a convenient, private, and rapid testing solution.

Key Market Challenges

Regulatory Hurdles and Compliance Issues

The global Methenamine market faces significant regulatory challenges, which may hinder its growth. Methenamine, due to its classification as a chemical compound with multiple industrial applications, is subject to stringent regulations across different countries. These regulations primarily focus on safety standards, environmental impact, and potential risks to human health. Governments in regions such as the European Union, North America, and Asia Pacific have imposed limits on the manufacturing and use of chemicals like Methenamine due to concerns over their toxicity and environmental effects. Companies in this sector must navigate complex regulatory frameworks, including safety certifications, environmental approvals, and product registrations, which can delay time-to-market and increase operational costs. Additionally, the evolving nature of regulatory policies and the potential introduction of new laws add uncertainty to the market landscape.

Key Market Trends

Technological Advancements in Methenamine Production

Technological innovations in Methenamine production are driving the expansion of the global market. As demand for Methenamine grows across various industries, more efficient and cost-effective manufacturing processes are essential to meet market needs. New advancements in production technologies, such as sustainable manufacturing methods and improved reaction conditions, have significantly reduced production costs and increased output. This has made Methenamine more accessible to industries requiring large quantities of the compound.

Key Market Players

• Shandong Shengxuelong Chemical Co., Ltd.
• UCC Shchekinoazot
• Sina Chemical Industries Company
• Henan Runhua Chemicals Co., Ltd.
• Guangzhou Hanpu Pharmaceutical Co. Ltd
• Zaozhuang Xudong Chemical Technology Co., Ltd.
• Simalin Chemical Industries Private Limited

Report Scope

This report segments the Global Methenamine Market into the following categories, along with detailed insights into industry trends:

Methenamine Market by End-Use:

• Synthetic Resin
• Rubber Industry
• Textile Industry
• Other Industries

Methenamine Market by Sales Channel:

• Direct Sales
• Indirect Sales

Methenamine Market by Region:

• North America: United States, Canada, Mexico
• Europe: France, United Kingdom, Italy, Germany, Spain
• Asia-Pacific: China, India, Japan, Australia, South Korea
• South America: Brazil, Argentina, Colombia
• Middle East & Africa: South Africa, Saudi Arabia, UAE

Competitive Landscape

Company Profiles: In-depth analysis of the leading companies operating in the Global Methenamine Market.

Available Customizations:

The Global Methenamine Market report can be customized based on specific company needs. Customization options include:

• Company Information: Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Methenamine Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By End-Use (Synthetic Resin, Rubber Industry, Textile Industry, and Others)
  • 5.2.2. By Sales Channel (Direct Sale and Indirect Sale)
  • 5.2.3. By Company (2024)
  • 5.2.4. By Region
• 5.3. Market Map

6. North America Methenamine Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By End-Use
  • 6.2.2. By Sales Channel
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Methenamine Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By End-Use
      • 6.3.1.2.2. By Sales Channel
  • 6.3.2. Mexico Methenamine Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By End-Use
      • 6.3.2.2.2. By Sales Channel
  • 6.3.3. Canada Methenamine Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By End-Use
      • 6.3.3.2.2. By Sales Channel

7. Europe Methenamine Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By End-Use
  • 7.2.2. By Sales Channel
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Methenamine Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By End-Use
      • 7.3.1.2.2. By Sales Channel
  • 7.3.2. Germany Methenamine Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By End-Use
      • 7.3.2.2.2. By Sales Channel
  • 7.3.3. United Kingdom Methenamine Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By End-Use
      • 7.3.3.2.2. By Sales Channel
  • 7.3.4. Italy Methenamine Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By End-Use
      • 7.3.4.2.2. By Sales Channel
  • 7.3.5. Spain Methenamine Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By End-Use
      • 7.3.5.2.2. By Sales Channel

8. Asia-Pacific Methenamine Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By End-Use
  • 8.2.2. By Sales Channel
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Methenamine Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By End-Use
      • 8.3.1.2.2. By Sales Channel
  • 8.3.2. India Methenamine Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By End-Use
      • 8.3.2.2.2. By Sales Channel
  • 8.3.3. South Korea Methenamine Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By End-Use
      • 8.3.3.2.2. By Sales Channel
  • 8.3.4. Japan Methenamine Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By End-Use
      • 8.3.4.2.2. By Sales Channel
  • 8.3.5. Australia Methenamine Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By End-Use
      • 8.3.5.2.2. By Sales Channel

9. South America Methenamine Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By End-Use
  • 9.2.2. By Sales Channel
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Methenamine Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By End-Use
      • 9.3.1.2.2. By Sales Channel
  • 9.3.2. Argentina Methenamine Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By End-Use
      • 9.3.2.2.2. By Sales Channel
  • 9.3.3. Colombia Methenamine Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By End-Use
      • 9.3.3.2.2. By Sales Channel

10. Middle East and Africa Methenamine Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By End-Use
  • 10.2.2. By Sales Channel
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Methenamine Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By End-Use
      • 10.3.1.2.2. By Sales Channel
  • 10.3.2. Saudi Arabia Methenamine Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By End-Use
      • 10.3.2.2.2. By Sales Channel
  • 10.3.3. UAE Methenamine Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By End-Use
      • 10.3.3.2.2. By Sales Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Shandong Shengxuelong Chemical Co., Ltd.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. UCC Shchekinoazot
• 14.3. Sina Chemical Industries Company
• 14.4. Henan Runhua Chemicals Co.,Ltd
• 14.5. Guangzhou Hanpu Pharmaceutical Co Ltd
• 14.6. Zaozhuang xudong chemical technology co., ltd.
• 14.7. Simalin Chemical Industries Private Limited

15. Strategic Recommendations

16. About Us & Disclaimer